Phenylketonuria: White-matter Changes Assessed by 3.0-T Magnetic Resonance (MR) Imaging, MR Spectroscopy and MR Diffusion

Overview

Journal Radiol Med

Specialty Radiology

Date 2009 Mar 12

PMID 19277839

Citations 20

Authors

T Scarabino

T Popolizio

M Tosetti

D Montanaro

G M Giannatempo

R Terlizzi

S Pollice

A Maiorana

N Maggialetti

A Carriero

V Leuzzi

U Salvolini

Affiliations

Soon will be listed here.

Abstract

Purpose: This study evaluated the sensitivity of a 3.0-Tesla (T) magnetic resonance imaging (MRI) in measuring cerebral phenylalanine using proton magnetic resonance spectroscopy and in assessing MR-documented white-matter changes by means of diffusion studies (diffusion-weighted imaging, apparent diffusion coefficient map; diffusion tensor imaging) in patients with phenylketonuria.

Materials And Methods: Thirty-two patients with the classical clinical and biochemical deficits of phenylketonuria underwent biochemical (blood phenylalanine), genotypic (phenylalanine hydroxylase gene) and radiological investigation by means of MRI, proton magnetic resonance spectroscopy and diffusion magnetic resonance imaging with a 3.0-T scanner.

Results: Periventricular and subcortical white-matter changes were detected on all MR scans. In 29/32 patients, proton magnetic resonance spectroscopy easily documented abnormal signal elevation at 7.36 ppm, corresponding to phenylalanine, despite its low concentration. Phenylalanine signal amplitude relative to the creatine/phosphocreatine signal increased linearly with blood phenylalanine values (r 0.7067; p<0.001). Diffusion MRI demonstrated hyperintensity in the areas exhibiting MRI changes as well as decreased apparent diffusion coefficient values, but fractional anisotropy indices were normal.

Conclusions: The high signal, together with better spectral, spatial, contrast and temporal resolution, makes the 3.0-T MR the most suitable technique in the study of the phenylketonuria. In particular, the multimodal approach with MRI, proton magnetic resonance spectroscopy and diffusion magnetic resonance imaging can provide more information than previous studies performed with low-field systems.

Citing Articles

Phenylketonuria: A Scoring System for Brain Magnetic Resonance Imaging.

Bako D, Ciki K Turk Arch Pediatr. 2023; 58(5):519-526.

PMID: 37670551 PMC: 10544386. DOI: 10.5152/TurkArchPediatr.2023.23081.

Neurological and imaging phenotypes of adults with untreated phenylketonuria: new cases and literature review.

Wang M, Wu C, Zhang Z J Neurol. 2023; 270(8):4060-4079.

PMID: 37162580 DOI: 10.1007/s00415-023-11760-9.

Novel imaging technologies for genetic diagnoses in the inborn errors of metabolism.

Gropman A, Anderson A J Transl Genet Genom. 2022; 4:429-445.

PMID: 35529470 PMC: 9075742. DOI: 10.20517/jtgg.2020.09.

A Retrospective Case Series Analysis of the Relationship Between Phenylalanine: Tyrosine Ratio and Cerebral Glucose Metabolism in Classical Phenylketonuria and Hyperphenylalaninemia.

McGinnity C, Barros D, Guedj E, Girard N, Symeon C, Walker H Front Neurosci. 2021; 15:664525.

PMID: 34220424 PMC: 8248344. DOI: 10.3389/fnins.2021.664525.

White and gray matter brain development in children and young adults with phenylketonuria.

Hawks Z, Hood A, Lerman-Sinkoff D, Shimony J, Rutlin J, Lagoni D Neuroimage Clin. 2019; 23:101916.

PMID: 31491833 PMC: 6627563. DOI: 10.1016/j.nicl.2019.101916.

References

Thompson A, Tillotson S, Smith I, Kendall B, Moore S, Brenton D . Brain MRI changes in phenylketonuria. Associations with dietary status. Brain. 1993; 116 ( Pt 4):811-21. DOI: 10.1093/brain/116.4.811. View

Frahm J, Hanefeld F . Localized proton magnetic resonance spectroscopy of cerebral metabolites. Neuropediatrics. 1996; 27(2):64-9. DOI: 10.1055/s-2007-973751. View

Cleary M, Walter J, Wraith J, Jenkins J, Alani S, Tyler K . Magnetic resonance imaging of the brain in phenylketonuria. Lancet. 1994; 344(8915):87-90. DOI: 10.1016/s0140-6736(94)91281-5. View

Battistini S, De Stefano N, Parlanti S, Federico A . Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment. Funct Neurol. 1991; 6(2):177-80. View

Leuzzi V, Tosetti M, Montanaro D, Artiola C, Carducci C, Antonozzi I . The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study. J Inherit Metab Dis. 2007; 30(2):209-16. DOI: 10.1007/s10545-006-0399-4. View

Leuzzi V, Trasimeni G, Gualdi G, Antonozzi I . Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients. J Inherit Metab Dis. 1995; 18(5):624-34. DOI: 10.1007/BF02436009. View

Weglage J, Wiedermann D, Denecke J, Feldmann R, Koch H, Ullrich K . Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria. Ann Neurol. 2001; 50(4):463-7. DOI: 10.1002/ana.1226. View

Phillips M, McGraw P, Lowe M, Mathews V, Hainline B . Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria. AJNR Am J Neuroradiol. 2001; 22(8):1583-6. PMC: 7974588. View

Cleary M, Walter J, Wraith J, White F, Tyler K, Jenkins J . Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr. 1995; 127(2):251-5. DOI: 10.1016/s0022-3476(95)70303-9. View

10.

Ullrich K, Weglage J, Schuierer G, Funders B, Pietsch M, Koch H . Cranial MRI in PKU: evaluation of a critical threshold for blood phenylalanine. Neuropediatrics. 1994; 25(5):278-9. DOI: 10.1055/s-2008-1073039. View

11.

Yin H, Tchoyoson Lim C, Ma L, Gao Y, Cai Y, Li D . Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis. J Neurol. 2004; 251(10):1249-54. DOI: 10.1007/s00415-004-0526-9. View

12.

Leuzzi V, Bianchi M, Tosetti M, Carducci C, Carducci C, Antonozzi I . Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria. J Inherit Metab Dis. 2000; 23(6):563-70. DOI: 10.1023/a:1005621727560. View

13.

Bick U, Ullrich K, Stober U, Moller H, Schuierer G, Ludolph A . White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr. 1993; 152(12):1012-20. DOI: 10.1007/BF01957228. View

14.

Leuzzi V, Gualdi G, Fabbrizi F, Trasimeni G, Di Biasi C, Antonozzi I . Neuroradiological (MRI) abnormalities in phenylketonuric subjects: clinical and biochemical correlations. Neuropediatrics. 1993; 24(6):302-6. DOI: 10.1055/s-2008-1071561. View

15.

McCombe P, McLaughlin D, Chalk J, Brown N, McGill J, Pender M . Spasticity and white matter abnormalities in adult phenylketonuria. J Neurol Neurosurg Psychiatry. 1992; 55(5):359-61. PMC: 489075. DOI: 10.1136/jnnp.55.5.359. View

16.

Brand A, Richter-Landsberg C, Leibfritz D . Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci. 1993; 15(3-5):289-98. DOI: 10.1159/000111347. View

17.

Wakana S, Jiang H, Nagae-Poetscher L, van Zijl P, Mori S . Fiber tract-based atlas of human white matter anatomy. Radiology. 2003; 230(1):77-87. DOI: 10.1148/radiol.2301021640. View

18.

Scarabino T, Nemore F, Giannatempo G, Bertolino A, di Salle F, Salvolini U . 3.0 T magnetic resonance in neuroradiology. Eur J Radiol. 2003; 48(2):154-64. DOI: 10.1016/j.ejrad.2003.08.008. View

19.

Graham J, Papadakis N, Evans J, Widjaja E, Romanowski C, Paley M . Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology. 2004; 63(11):2111-9. DOI: 10.1212/01.wnl.0000145766.03057.e7. View

20.

Mori S, Kaufmann W, Davatzikos C, Stieltjes B, Amodei L, Fredericksen K . Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn Reson Med. 2002; 47(2):215-23. DOI: 10.1002/mrm.10074. View